Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies - Plaimauer, B; Kremer, JA Hovinga; Juno, C (J Thromb Haemost, 2011)
et al.